Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15080 | 732 | 30.0 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
15080 | 1 | VIGABATRIN//GAMMA VINYL GABA//VISUAL FIELD CONSTRICTION | 732 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VIGABATRIN | authKW | 4459688 | 34% | 43% | 246 |
2 | GAMMA VINYL GABA | authKW | 330945 | 3% | 36% | 22 |
3 | VISUAL FIELD CONSTRICTION | authKW | 320869 | 1% | 77% | 10 |
4 | REFRACTORY COMPLEX PARTIAL SEIZURES | authKW | 291995 | 1% | 100% | 7 |
5 | INTRAMYELINIC EDEMA | authKW | 148306 | 1% | 44% | 8 |
6 | AUDITORY DISTURBANCE | authKW | 111234 | 1% | 67% | 4 |
7 | MARYLAND EYE CARE | address | 93854 | 0% | 75% | 3 |
8 | VISUAL FIELD DEFECT | authKW | 93085 | 3% | 9% | 24 |
9 | VISUAL FIELD LOSS | authKW | 85791 | 2% | 17% | 12 |
10 | REGULATORY DEV REGISTRAT | address | 83427 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 10525 | 52% | 0% | 380 |
2 | Ophthalmology | 1039 | 11% | 0% | 78 |
3 | Neurosciences | 875 | 22% | 0% | 160 |
4 | Pharmacology & Pharmacy | 688 | 20% | 0% | 145 |
5 | Pediatrics | 213 | 7% | 0% | 50 |
6 | Psychiatry | 197 | 7% | 0% | 51 |
7 | Behavioral Sciences | 84 | 3% | 0% | 21 |
8 | Toxicology | 35 | 3% | 0% | 21 |
9 | Medicine, General & Internal | 20 | 4% | 0% | 31 |
10 | Engineering, Biomedical | 10 | 2% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MARYLAND EYE CARE | 93854 | 0% | 75% | 3 |
2 | REGULATORY DEV REGISTRAT | 83427 | 0% | 100% | 2 |
3 | CARDIFF OPTOMETRY VIS SCI | 68250 | 1% | 27% | 6 |
4 | NEUROPHARMACOL PRECLIN TOXICOL | 55617 | 0% | 67% | 2 |
5 | BE WELL | 41714 | 0% | 100% | 1 |
6 | C MONDINO FDNCHILD NEUROPSYCHIAT | 41714 | 0% | 100% | 1 |
7 | CARE OF ST ANDREA HOSP | 41714 | 0% | 100% | 1 |
8 | CELL NEUROBIOL DOHERTY EYE | 41714 | 0% | 100% | 1 |
9 | DIPARTIMENTO SALUTE PUBBLICA BIOSTATISTICA | 41714 | 0% | 100% | 1 |
10 | DRUG SAFETY EACH UNIT | 41714 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSIA | 33848 | 12% | 1% | 85 |
2 | EPILEPSY RESEARCH | 15530 | 5% | 1% | 38 |
3 | SEIZURE | 10934 | 1% | 7% | 4 |
4 | AKTUELLE NEUROLOGIE | 7540 | 2% | 1% | 18 |
5 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 5542 | 2% | 1% | 18 |
6 | ACTA NEUROLOGICA SCANDINAVICA | 4986 | 4% | 0% | 27 |
7 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 4291 | 4% | 0% | 29 |
8 | DOCUMENTA OPHTHALMOLOGICA | 4173 | 2% | 1% | 15 |
9 | JOURNAL OF CHILD NEUROLOGY | 2762 | 2% | 0% | 18 |
10 | NEUROLOGY | 2234 | 5% | 0% | 34 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VIGABATRIN | 4459688 | 34% | 43% | 246 | Search VIGABATRIN | Search VIGABATRIN |
2 | GAMMA VINYL GABA | 330945 | 3% | 36% | 22 | Search GAMMA+VINYL+GABA | Search GAMMA+VINYL+GABA |
3 | VISUAL FIELD CONSTRICTION | 320869 | 1% | 77% | 10 | Search VISUAL+FIELD+CONSTRICTION | Search VISUAL+FIELD+CONSTRICTION |
4 | REFRACTORY COMPLEX PARTIAL SEIZURES | 291995 | 1% | 100% | 7 | Search REFRACTORY+COMPLEX+PARTIAL+SEIZURES | Search REFRACTORY+COMPLEX+PARTIAL+SEIZURES |
5 | INTRAMYELINIC EDEMA | 148306 | 1% | 44% | 8 | Search INTRAMYELINIC+EDEMA | Search INTRAMYELINIC+EDEMA |
6 | AUDITORY DISTURBANCE | 111234 | 1% | 67% | 4 | Search AUDITORY+DISTURBANCE | Search AUDITORY+DISTURBANCE |
7 | VISUAL FIELD DEFECT | 93085 | 3% | 9% | 24 | Search VISUAL+FIELD+DEFECT | Search VISUAL+FIELD+DEFECT |
8 | VISUAL FIELD LOSS | 85791 | 2% | 17% | 12 | Search VISUAL+FIELD+LOSS | Search VISUAL+FIELD+LOSS |
9 | VIGABATRIN TOXICITY | 83427 | 0% | 100% | 2 | Search VIGABATRIN+TOXICITY | Search VIGABATRIN+TOXICITY |
10 | AMINOBUTYRATE AMINOTRANSFERASE | 74153 | 1% | 44% | 4 | Search AMINOBUTYRATE+AMINOTRANSFERASE | Search AMINOBUTYRATE+AMINOTRANSFERASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WATERHOUSE, EJ , MIMS, KN , GOWDA, SN , (2009) TREATMENT OF REFRACTORY COMPLEX PARTIAL SEIZURES: ROLE OF VIGABATRIN.NEUROPSYCHIATRIC DISEASE AND TREATMENT. VOL. 5. ISSUE . P. 505-515 | 66 | 85% | 17 |
2 | PLANT, GT , SERGOTT, RC , (2011) UNDERSTANDING AND INTERPRETING VISION SAFETY ISSUES WITH VIGABATRIN THERAPY.ACTA NEUROLOGICA SCANDINAVICA. VOL. 124. ISSUE . P. 57 -71 | 63 | 78% | 16 |
3 | MAGUIRE, MJ , HEMMING, K , WILD, JM , HUTTON, JL , MARSON, AG , (2010) PREVALENCE OF VISUAL FIELD LOSS FOLLOWING EXPOSURE TO VIGABATRIN THERAPY: A SYSTEMATIC REVIEW.EPILEPSIA. VOL. 51. ISSUE 12. P. 2423 -2431 | 43 | 96% | 42 |
4 | SERGOTT, RC , WHELESS, JW , SMITH, MC , WESTALL, CA , KARDON, RH , ARNOLD, A , FOROOZAN, R , SAGAR, SM , (2010) EVIDENCE-BASED REVIEW OF RECOMMENDATIONS FOR VISUAL FUNCTION TESTING IN PATIENTS TREATED WITH VIGABATRIN.NEURO-OPHTHALMOLOGY. VOL. 34. ISSUE 1. P. 20 -35 | 44 | 85% | 14 |
5 | KJELLSTROM, U , ANDREASSON, S , PONJAVIC, V , (2011) ELECTROPHYSIOLOGICAL EVALUATION OF RETINAL FUNCTION IN CHILDREN RECEIVING VIGABATRIN MEDICATION.JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS. VOL. 48. ISSUE 6. P. 357-365 | 49 | 77% | 0 |
6 | GRANT, SM , HEEL, RC , (1991) VIGABATRIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN EPILEPSY AND DISORDERS OF MOTOR CONTROL.DRUGS. VOL. 41. ISSUE 6. P. 889-926 | 74 | 67% | 254 |
7 | GIDAL, BE , PRIVITERA, MD , SHETH, RD , GILMAN, JT , (1999) VIGABATRIN: A NOVEL THERAPY FOR SEIZURE DISORDERS.ANNALS OF PHARMACOTHERAPY. VOL. 33. ISSUE 12. P. 1277 -1286 | 62 | 78% | 23 |
8 | PELLOCK, JM , (2011) BALANCING CLINICAL BENEFITS OF VIGABATRIN WITH ITS ASSOCIATED RISK OF VISION LOSS.ACTA NEUROLOGICA SCANDINAVICA. VOL. 124. ISSUE . P. 83 -91 | 47 | 72% | 7 |
9 | WHELESS, JW , RAMSAY, RE , COLLINS, SD , (2007) VIGABATRIN.NEUROTHERAPEUTICS. VOL. 4. ISSUE 1. P. 163-172 | 55 | 65% | 30 |
10 | KJELLSTROM, U , ANDREASSON, S , PONJAVIC, V , (2014) ATTENUATION OF THE RETINAL NERVE FIBRE LAYER AND REDUCED RETINAL FUNCTION ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY AND FULL-FIELD ELECTRORETINOGRAPHY IN PATIENTS EXPOSED TO VIGABATRIN MEDICATION.ACTA OPHTHALMOLOGICA. VOL. 92. ISSUE 2. P. 149-157 | 38 | 79% | 6 |
Classes with closest relation at Level 1 |